KAMRYN MEAD: Open Payments
NPI 1033834692 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,494 in 75 payments from 13 companies in 2025. Trend: 2023 $1,328 · 2024 $2,017 · 2025 $1,494
Food & beverage: $1,494
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $446 |
| AstraZeneca Pharmaceuticals LP | 14 | $284 |
| Lilly USA, LLC | 11 | $177 |
| Phathom Pharmaceuticals, Inc. | 4 | $166 |
| Amgen Inc. | 10 | $138 |
| ABBVIE INC. | 2 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $63 |
| Sumitomo Pharma America, Inc. | 3 | $54 |
| Seqirus USA Inc | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $24 |
Products named: Ozempic, MOUNJARO, VOQUEZNA, Wegovy, OTEZLA, BREZTRI, AIRSUPRA, VRAYLAR.
Industry payments across TN — which companies pay providers there.
